These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38059357)
41. PRAME immunohistochemistry is useful in the evaluation of conjunctival melanomas, nevi, and primary acquired melanosis. LeBlanc RE; Miller DM; Zegans ME J Cutan Pathol; 2021 Dec; 48(12):1442-1448. PubMed ID: 34089198 [TBL] [Abstract][Full Text] [Related]
42. Meyerson Phenomenon as a Component of Melanoma in situ. Sezer E; Özturk Durmaz E; Çetin E; Şahin S Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137 [TBL] [Abstract][Full Text] [Related]
46. Defining the Histopathological Term Atypical Intraepidermal Melanocytic Proliferation: A Retrospective Cross-Sectional Study. Bou-Prieto A; Sarriera-Lázaro CJ; Valentín-Nogueras SM; Sánchez JE; Sánchez JL Am J Dermatopathol; 2021 Apr; 43(4):252-258. PubMed ID: 33201012 [TBL] [Abstract][Full Text] [Related]
47. Melanoma and melanoma in-situ diagnosis after excision of atypical intraepidermal melanocytic proliferation: A retrospective cross-sectional analysis. Blank NR; Hibler BP; Tattersall IW; Ensslin CJ; Lee EH; Dusza SW; Nehal KS; Busam KJ; Rossi AM J Am Acad Dermatol; 2019 May; 80(5):1403-1409. PubMed ID: 30654079 [TBL] [Abstract][Full Text] [Related]
48. Molecular testing in melanoma for the surgical pathologist. Andea AA Pathology; 2023 Mar; 55(2):245-257. PubMed ID: 36653236 [TBL] [Abstract][Full Text] [Related]
49. TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis. Motaparthi K; Kim J; Andea AA; Missall TA; Novoa RA; Vidal CI; Fung MA; Emanuel PO J Cutan Pathol; 2020 Aug; 47(8):710-719. PubMed ID: 32202662 [TBL] [Abstract][Full Text] [Related]
50. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. Marušić Z; Buljan M; Busam KJ J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915 [TBL] [Abstract][Full Text] [Related]
51. Atypical histopathologic features in a melanocytic nevus after cryotherapy and pregnancy. Wilford CE; Brantley JS; Diwan AH J Cutan Pathol; 2014 Oct; 41(10):802-5. PubMed ID: 25351287 [TBL] [Abstract][Full Text] [Related]
52. A Physician's Guide to the Use of Gene Expression Profile Ancillary Diagnostic Testing for Cutaneous Melanocytic Neoplasms. Marks E; Jarell A; Ludzik J; Farberg AS; Rabinovitz HS; Phelps RG; Cockerell CJ; Witkowski A J Clin Aesthet Dermatol; 2023 Apr; 16(4):12-20. PubMed ID: 37077930 [TBL] [Abstract][Full Text] [Related]
53. Common and not so Common Melanocytic Lesions in Children and Adolescents. Yang C; Gru AA; Dehner LP Pediatr Dev Pathol; 2018; 21(2):252-270. PubMed ID: 29607755 [TBL] [Abstract][Full Text] [Related]
54. Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology. Zaremba A; Lodde G; Murali R; Philip M; Cosgarea I; Jansen P; Chorti E; Rose C; Hemmerlein B; Matull J; Thielmann CM; Kretz J; Möller I; Sucker A; Paschen A; Livingstone E; Zimmer L; Horn S; Schadendorf D; Hadaschik E; Griewank K Eur J Cancer; 2021 May; 148():340-347. PubMed ID: 33773277 [TBL] [Abstract][Full Text] [Related]
55. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors. Zaremba A; Jansen P; Murali R; Mayakonda A; Riedel A; Philip M; Rose C; Schaller J; Müller H; Kutzner H; Möller I; Stadtler N; Kretz J; Sucker A; Bankfalvi A; Livingstone E; Zimmer L; Horn S; Paschen A; Plass C; Schadendorf D; Hadaschik E; Lutsik P; Griewank K Int J Cancer; 2022 Nov; 151(9):1542-1554. PubMed ID: 35737508 [TBL] [Abstract][Full Text] [Related]
56. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases]. Mérot Y; Mihm MC Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131 [TBL] [Abstract][Full Text] [Related]
57. Proliferative activity of primary cutaneous melanocytic tumours. Kuwata T; Kitagawa M; Kasuga T Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909 [TBL] [Abstract][Full Text] [Related]
58. Mesenchymal tumours with melanocytic expression: a potential pitfall in the differential diagnosis of malignant melanoma. Saleh JS; Whittington CP; Bresler SC; Patel RM Pathology; 2023 Mar; 55(2):258-268. PubMed ID: 36639332 [TBL] [Abstract][Full Text] [Related]
59. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study. Santucci M; Urso C; Giannini A; Bondi R Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799 [TBL] [Abstract][Full Text] [Related]
60. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]